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Abstract The remarkable capacity of some viruses to
adapt to new hosts and environments is highly dependent
on their ability to generate de novo diversity in a short
period of time. Rates of spontaneous mutation vary amply
among viruses. RNA viruses mutate faster than DNA
viruses, single-stranded viruses mutate faster than double-
strand virus, and genome size appears to correlate nega-
tively with mutation rate. Viral mutation rates are
modulated at different levels, including polymerase fide-
lity, sequence context, template secondary structure,
cellular microenvironment, replication mechanisms,
proofreading, and access to post-replicative repair. Addi-
tionally, massive numbers of mutations can be introduced
by some virus-encoded diversity-generating elements, as
well as by host-encoded cytidine/adenine deaminases. Our
current knowledge of viral mutation rates indicates that
viral genetic diversity is determined by multiple virus- and
host-dependent processes, and that viral mutation rates can
evolve in response to specific selective pressures.
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Abbreviations
APOBEC Apolipoprotein B mRNA-editing catalytic
polypeptide-like enzymes
ADAR dsRNA-dependent adenosine deaminase
AZT Azidothymidine
CTL Cytotoxic T lymphocyte
DDR DNA damage response
HBV Hepatitis B virus
HCV Hepatitis C virus
MMR Methyl-directed mismatch repair
PKR Protein kinase R
ROS Reactive oxygen species
SHAPE Selective 20-hydroxyl acylation analyzed by
primer extension
UNG Uracil DNA glycosylases
Introduction
The mutation rate of an organism is defined as the proba-
bility that a change in genetic information is passed to the
next generation. In viruses, a generation is often defined as
a cell infection cycle, which includes attachment to the cell
surface, entry, gene expression, replication, encapsidation,
and release of infectious particles. Mutations are not
restricted to replication since they can also result from
editing of the genetic material, or spontaneous nucleic acid
damage. The mutation rate should not be confused with the
frequency at which mutations are found in a given viral
population. The latter is a measure of genetic variation that
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depends on a number of other processes such as natural
selection, random genetic drift, recombination, and so on
(Fig. 1a). Higher mutation rates lead to higher genetic
diversity but, except in special cases, it is not possible to
infer mutation rates directly from observed population
mutation frequencies [1]. Although genetic diversity
depends on multiple factors, the mutation rate is of par-
ticular interest because it constitutes the ultimate source of
genetic variation. Similarly, mutation rates should not be
confused with molecular evolutionary rates. The neutral
theory of molecular evolution posits a linear relationship
between these two rates, but whereas mutation is a bio-
chemical/genetic process, molecular evolution refers to the
fixation of new alleles in populations [2, 3].
Knowledge of the processes underlying viral mutation
rates has implications for understanding and managing
drug resistance, immune escape, vaccination, pathogenesis,
and the emergence of new diseases. In clinics, the impor-
tance of viral mutation rates can be illustrated by the
history of anti-HIV treatment. The nucleoside analog azi-
dothymidine (AZT) was the first approved anti-HIV drug
but, unfortunately, the appearance of drug-resistant vari-
ants rapidly frustrated this monotherapy. HIV-1 is a fast-
mutating virus and produces every possible single-base
substitution (including AZT-resistance mutations) within a
patient everyday [4]. The subsequent success of highly
active antiretroviral therapy did not reside on merely
increasing drug potency but mainly in combining different
drugs (including AZT), such that the chances of resistance
mutations appear were minimized. Qualitatively, the same
argument holds for other rapidly mutating viruses such as
hepatitis C virus (HCV). Multiple resistances have been
already described against new HCV treatments [5], and
analysis of population sequences has shown that resistance
to protease inhibitors and non-nucleoside polymerase
inhibitors pre-exist naturally in treatment-naı¨ve patients,
that is, in the absence of selection favoring these mutations
[6]. At present, combination therapies are the only effective
treatment strategy for chronic diseases caused by fast-
mutating viruses.
A similar scenario can be depicted for antiviral immu-
nity. Viruses showing high mutation rates tend to evade
immunity more efficiently. There are numerous examples
of cytotoxic T lymphocyte (CTL) and antibody evasion in
HIV-1, HCV, and hepatitis B virus (HBV), three fast-mu-
tating viruses causing chronic infections. In HBV, the most
common cause of hepatitis worldwide with nearly 350
million people chronically infected, a series of point
mutations have been associated with immune escape and
vaccination failure [7]. In acute viruses, immune escape
takes place at the host population level instead of at the
intra-host level. In this case, the benefit of escape resides in
the ability of the virus to re-infect hosts that have devel-
oped protective immunity or infect hosts with that
recognize the same antigens. The best-known example is
influenza virus, which constantly undergoes antigenic
changes and therefore requires yearly vaccine updates.
Current efforts focus on developing influenza vaccines that
target evolutionarily more conserved, yet sufficiently
immunogenic protein domains [8]. Viral genetic diversity,
which is ultimately determined by mutation rates, has
therefore a profound effect on the design of antiviral
strategies.
Viral mutation rates are not merely caused by poly-
merase errors, but also by the ability of a virus to correct
DNA mismatches by proofreading and/or post-replicative
repair. Furthermore, other sources of mutation include host
enzymes, spontaneous nucleic acid damage, and even
special genetic elements located within some viral gen-
omes whose specific function is to produce new mutations
Fig. 1 Mutation rate definition. a Basic processes determining
population genetic diversity. The observed population frequency of
a mutation depends on the rate at which it is produced (mutation rate),
but also on natural selection, random genetic drift, and recombination,
among other processes. Most mutations are deleterious and tend to be
removed from the population by selection, whereas beneficial
mutations or combinations of mutations can be maintained/favored.
Recombination can also contribute to the maintenance of genetic
diversity. Random genetic drift leads to allele fixation and hence
reduces population genetic diversity. b Basic processes determining
viral mutation rates. Mutations originate from replication errors,
nucleic acid damage, and editing of the genetic material by host-
encoded proteins or by specialized molecular systems such as
diversity-generating retro-elements (DGRs). If these changes are not
corrected, they will be passed to the viral progeny and hence will
contribute to elevating the viral mutation rate. Expression of host
error-prone polymerases may also contribute to creating new
mutations in viruses. Recombination can also enhance the ability of
some viruses to create new mutations by increasing gene copy
number or by producing genome rearrangements
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(Fig. 1b). Mutation rates are modulated by additional fac-
tors, including proteins involved in replication other than
the polymerase, the mode of replication, and the template
sequence and structure. In this review, we discuss how
these different factors control viral mutation rates.
RNA viruses versus DNA viruses
The Baltimore classification of viruses establishes the fol-
lowing categories according to the genetic material
contained in the virion: positive-strand RNA viruses (e.g.,
rhinoviruses, hepatitis C virus, noroviruses, tobacco mosaic
virus), negative-strand RNA viruses (influenza viruses,
Ebola virus, rabies virus), double-strand RNA viruses (ro-
taviruses, bursal disease virus), retroviruses (HIV, human T
cell leukemia virus), para-retroviruses (hepatitis B viruses),
single-stranded DNA viruses (parvoviruses, bacteriophage
/X174), and double-stranded DNA viruses (papillo-
maviruses, herpesviruses, adenoviruses, poxviruses).
Viruses are the biological systems with the widest variation
in mutation rates, the largest differences being found
between RNA and DNA viruses. A summary of mutation
rates for different viruses is provided in Table 1. As dis-
cussed in previous work, the reliability of some of these
rates is compromised by several sources of estimation error
and bias [1]. Despite these uncertainties, it can be inferred
that viral mutation rates roughly range between 10-8 and
10-4 substitutions per nucleotide per cell infection (s/n/c),
with DNA viruses occupying the 10-8–10-6 range and
RNA viruses the 10-6–10-4 range (Fig. 2a). These dif-
ferences have several mechanistic bases. First, the
polymerases of the vast majority of RNA viruses lack 30
exonuclease proofreading activity and hence are more
error-prone than those of DNA viruses [9, 10]. The
exception to this rule is provided by coronaviruses, a
family of positive-strand RNA viruses encoding a complex
RNA-dependent RNA polymerase that has a 30 exonucle-
ase domain [11]. Reverse transcriptases (RTs) also lack 30
exonuclease activity [12, 13] and, hence, retroviruses
(viruses with RNA-containing virions and a cellular DNA
stage) and para-retroviruses (viruses with DNA-containing
virions and a cellular RNA stage) mutate and evolve at
rates similar to those of non-reverse transcribing RNA
viruses (the latter are often called riboviruses).
Whereas the dichotomy between RNA/RT and DNA
viruses is well established from genetic and mechanistic
standpoints, differences are less clear from the point of
view of molecular evolution [14]. Some DNA viruses have
been shown to evolve at rates close to those of RNA
viruses, including emerging canine parvovirus strains [15],
human parvovirus [16], tomato yellow leaf curl gemi-
nivirus [17], beak-and-feather disease circovirus [18], and
African swine fever virus (ASFV) [19], among others. This
underscores the fact that evolution depends on multiple
factors other than mutation rate, but also that mutation rates
are unknown for many DNA viruses and may, in some
cases, be higher than currently believed. Recent work with
human cytomegalovirus has suggested a genome-wide
average of 2 9 10-7 s/n/c, a value slightly higher than
previously thought for a large double-strand DNA virus
[20], although this estimate was indirect. Since many DNA
and RNA viruses share similar lifestyles, the question
arises as to why mutation rates should have evolved so
differently in these two broad groups.
Single-strand viruses show higher mutation rates
than double-strand viruses
Single-strand DNA viruses tend to mutate faster than
double-strand DNA viruses, although this difference is
based on work with bacteriophages, as no mutation rate
estimates have been obtained for eukaryotic single-strand
DNA viruses [1]. Within RNA viruses, there are no obvi-
ous differences in mutation rate among Baltimore classes
(Fig. 2a). The mechanisms underlying these differences are
not well understood. One possible explanation for the dif-
ferences between single and double-strand viruses is that
single-strand nucleic acids are more prone to oxidative
deamination and other types of chemical damage. Elevated
levels of reactive oxygen species (ROS) and other cellular
metabolites during viral infections can induce mutations in
the host cell and in the virus. For instance, ethanol is likely
to synergize with virus-induced oxidative stress to increase
the mutation rate of HCV [21]. Differences among single-
and double-strand DNA viruses may also be explained in
terms of their access to post-replicative repair. Work with
bacteriophage /X174 has provided interesting clues on this
issue. In enterobacteria, methyl-directed mismatch repair
(MMR) is performed by MutHLS proteins and Dam
methylase. Dam methylation of GATC sequence motifs is
used to differentiate the template and daughter DNA
strands and is thus required to perform mismatch correction
[22]. Mismatches are recognized by MutS, which interacts
with MutL and leads to the activation of the MutH
endonuclease, which excises the daughter strand. However,
the genome of bacteriophage /X174 has no GATC
sequence motifs, even if approximately 20 such sites are
expected by chance. As a result, the /X174 DNA cannot
undergo MMR. This contributes to explaining the rela-
tively high mutation rate of this virus, which falls on the
order of 10-6 s/n/c, a value three orders of magnitude
above that of Escherichia coli and highest among DNA
viruses [23]. Avoidance of GATC motifs may be a con-
sequence of selection acting on mutation rate, but also of
Mechanisms of viral mutation 4435
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other selective factors. For instance, inefficient methylation
of the phage DNA may render it susceptible to cleavage by
MutH, therefore imposing a selection pressure against
GATC sequence motifs [24].
As opposed to bacteriophage /X174, the link between
post-replicative repair and mutation rate is still unclear in
eukaryotic viruses. Numerous studies have shown that
viruses interact with DNA damage response (DDR) path-
ways by altering the localization or promoting the
degradation of DDR components [25, 26]. For instance, the
adenoviral E4orf6 protein promotes proteasomal degrada-
tion of TOPBP1, a DDR component [27]. DDR activation
can occur as an indirect consequence of cellular stress due
to the infection per se or as a part of an antiviral response,
which would be in turn counteracted by viruses. Although
DNA viruses tend to promote genomic instability in the
host cell, it remains to be shown whether DDR dysregu-
lation can determine DNA virus mutation rates.





Individual estimates (s/n/c)b and references
ss(?)RNA Bacteriophage Qbc 4.22 1.4 9 10-4 1.4 9 10-4 [29]
Tobacco mosaic virus 6.40 8.7 9 10-6 8.7 9 10-6 [128]
Human rhinovirus 14 7.13 6.9 9 10-5 4.8 9 10-4 [129], 1.0 9 10-5 [130]
Poliovirus 1 7.44 9.0 9 10-5 2.2 9 10-5 [131, 132], 1.1 9 10-4 [133],
3.0 9 10-4 [134]
Human norovirus G1 7.65 1.5 9 10-4 1.5 9 10-4 [74]
Tobacco etch virus 9.49 1.2 9 10-5 3.0 9 10-5 [135], 4.8 9 10-6 [136]
Hepatitis C virus 9.65 3.8 9 10-5 1.2 9 10-4 [137], 2.5 9 10-5 [138], 2.0 9 10-5
[138], 3.5 9 10-5 [105]
Murine hepatitis virus 31.4 3.5 9 10-6 3.5 9 10-6 [139]
ss(-)RNA Vesicular stomatitis virus 11.2 3.7 9 10-5 6.9 9 10-5 [140, 141], 1.8 9 10-5 [142],
4.2 9 10-5 [143]
Influenza A virus 13.6 2.5 9 10-5 4.5 9 10-5 [144], 7.1 9 10-6 [145], 3.9 9 10-5
[146], 3.1 9 10-5 [147]
Measles virusd 15.9 3.5 9 10-5 2.8 9 10-5 [148], 4.4 9 10-5 [149]
dsRNA Bacteriophage U6 13.4 1.6 9 10-6 1.6 9 10-6 [82]
Reverse transcribing Duck hepatitis B virus 3.03 2.0 9 10-5 2.0 9 10-5 [150]
Spleen necrosis virus 7.80 3.7 9 10-5 2.4 9 10-5 [151], 5.8 9 10-5 [152]
Murine leukemia virus 8.33 3.0 9 10-5 6.0 9 10-6 [153], 4.2 9 10-5 [154], 1.1 9 10-4
[155, 156]
Bovine leukemia virus 8.42 1.7 9 10-5 1.7 9 10-5 [157]
Human T-cell leukemia virus 8.50 1.6 9 10-5 1.6 9 10-5 [158]
HIV-1 (free virions) 9.18 6.3 9 10-5 4.9 9 10-5 [76, 159, 160], 1.0 9 10-4 [161],
8.7 9 10-5 [162], 4.4 9 10-5 [163], 3.6 9 10-5
[99], 9.3 9 10-5 [63]
HIV-1 (cellular DNA) 9.18 4.4 9 10-3 4.4 9 10-3 [63]
Foamy virus 13.2 2.1 9 10-5 2.1 9 10-5 [164]
Rous sarcoma virus 9.40 1.4 9 10-4 1.4 9 10-4 [165]
ssDNA Bacteriophage UX174 5.39 1.1 9 10-6 1.3 9 10-6 [166], 1.0 9 10-6 [23]
Bacteriophage m13 6.41 7.9 9 10-7 7.9 9 10-7 [94]
dsDNA Bacteriophage k 48.5 5.4 9 10-7 5.4 9 10-7 [167, 168]
Herpes simplex virus 152 5.9 9 10-8 5.9 9 10-8 [169, 170]
Bacteriophage T2 169 9.8 9 10-8 9.8 9 10-8 [167, 171]
Human cytomegalovirus 235 2.0 9 10-7 2.0 9 10-7 [20]
a Geometric mean of the individual estimates
b Mutation rates were normalized to s/n/c units as detailed in previous work [1]
c This corresponds to a consensus estimate from several studies, see original publication for details
d Assuming linear replication, see original references for details
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Viruses with smaller genomes tend to mutate faster
A general inverse correlation between genome size and
mutation rate applies to DNA-based microorganisms
including viruses, bacteria and unicellular eukaryotes [28].
According to this rule, the per-genome mutation rate stays
relatively constant at a value of approximately 0.003 per
round of copy. A similar negative relationship seems to
exist in RNA viruses, but their smaller genome size range
of variation makes it more difficult to detect such trend
(Fig. 2b). Supporting this correlation, however, coron-
aviruses have the largest genomes among RNA viruses
(30–33 kb) and have evolved proofreading capacity, as
opposed to all other RNA viruses known [11]. Conversely,
one of the highest mutation rate described for a ribovirus
corresponds to bacteriophage Qb, which has one of the
smallest RNA genomes [29]. Therefore, there appears to be
a general negative correlation between mutation rates and
genome size in microorganisms. However, the underlying
causes remain unclear, both at the mechanistic and evolu-
tionary levels. First, there are no known differences in
intrinsic replication fidelity among the polymerases of
different RNA viruses (excepting coronavirus exonuclease
activity). Second, in DNA viruses, those with higher esti-
mated mutation rates have smaller genomes, but also have
single-strand DNA (Fig. 2). Estimates for small double-
strand DNA viruses would be needed to clarify which of
these two factors contributes more to elevating mutation
rates. The observation that most highly variable and rapidly
evolving DNA viruses have small genomes (including
double-strand viruses) indirectly supports an effect of
genome size [3].
Candidatemechanisms thatmight account formutation rate
differences between large and small DNAvirusesmay involve
virus–DDR interactions. Whereas many viruses appear to
evadeDDR, others seem to use it for their own benefit [25, 26].
Polyomaviruses, papillomaviruses and parvoviruses induce
and depend on DDR signaling pathways for efficient replica-
tion [30–32]. These viruses share the property of having small,
circular DNA genomes which do not encode a polymerase. As
such, they depend directly on the cellular replication machin-
ery, as opposed to larger DNA viruses. It is possible that some
small viruses promote the DDR to prolong the S cell-cycle
phase, which offers a more favorable environment for repli-
cation. By adopting circular genomes, these viruseswould also
avoid the formation of genome concatemers, a typical effect of
DDR in linear viral genomes such as, for instance, aden-
oviruses [33].Whether differences inDDR activation between
small/circular and large/linear DNA viruses translate into
mutation rate differences remains to be tested. The DDR
comprises error-prone DNA polymerases for re-synthesis of
excised strands [34], and involvement of these polymerases in
viral replication may lead to higher mutation rates.
Polymerase fidelity variants
Intrinsic polymerase fidelity (i.e., the ability to incorporate
the correct base and exclude incorrect bases from the active
site during DNA synthesis) is a primary mutation rate
Fig. 2 Mutation rate variation across viruses. a Range of variation of
mutation rates for the seven Baltimore classes of viruses (ss single-
strand, ds double-strand; ?/- genome polarity, RT retroviruses, pRT
para-retroviruses). In the RT group, all mutation rates fall in the non-
hatched arrow region except the HIV-1 mutation rate measured in
cellular DNA, which is orders of magnitude higher than the rate
measured in plasma. This is because many APOBEC-edited viral
genomes fail to produce viable progeny and hence do not reach
plasma (see text for details). b Negative correlation between genome
size and mutation rate in viruses. Baltimore groups are indicated. The
observed correlation can be explained in terms of differences between
RNA and DNA viruses and between ss and ds viruses. In the RT
group, the extremely high mutation rate of HIV-1 in cellular DNA is
indicated with an arrow. In contrast, the HIV-1 mutation rate
measured in plasma falls within the usual RT range
Mechanisms of viral mutation 4437
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determinant. Polymerase variants with altered fidelity have
been artificially selected in a number of RNA viruses by
subjecting laboratory populations to mutagenic treatments
[35]. For instance, serial passaging of poliovirus in the
presence of the base analog ribavirin led to the selection of
a polymerase variant (G64S) with threefold increased
fidelity [36]. This same mutation also confers increased
fidelity in the related human enterovirus 71 [37], and other
amino acid replacements such as L123F have also been
shown to modify the replication fidelity of this virus [38].
Passaging of coxsackievirus B3 (also a member of the
enterovirus genus in the picornavirus family) in the pres-
ence of ribavirin or 5-azacytidine selected for another
fidelity variant in the viral polymerase (A372V) [39].
Outside picornaviruses, fidelity variants have been more
recently obtained by serial mutagen treatment in chikun-
gunya virus [40], influenza A virus [41], and West Nile
virus [42]. Several antivirals and notably many antiretro-
viral drugs are base analogs. Resistance to these treatments
is well documented in the HIV-1 RT and some of these
variants modify replication fidelity, as determined in vitro
or in cell cultures [13]. Intrinsic fidelity can be determined
by residues located inside or outside the catalytic domain
[43, 44]. For instance, reorientation of the triphosphate
moiety of the incoming nucleotide is a fidelity checkpoint
in poliovirus polymerase [45]. Interestingly, recent work
has shown that replication fidelity can also be determined
by proteins of the replication complex other than the viral
polymerase. Serial passages of chikungunya virus in the
presence of nucleoside analogs favored the appearance of
substitution G641D in the RNA helicase nsP2 [40]. This
variant increased replication fidelity through mechanisms
linked to reduced helicase activity, increased replication
kinetics, and resistance to low nucleotide concentrations
[46]. Fidelity variants demonstrate the ability of RNA
viruses to evolutionarily adjust mutation rates in response
to selection acting on mutation rate or other traits.
DNA virus mutation rates also respond to selection, as
shown in earlier work with bacteriophage T4 in which a
series of polymerase variants were identified following
chemical mutagenesis [47]. T4 polymerase variants
showing strongly increased fidelity have been described (as
opposed to more modest effects in RNA viruses) and tend
to map to the central palm and the carboxyl-terminal thumb
subdomain of the viral polymerase. Mutator phenotypes
have also been described in T4. This phenotype can be
conferred by changes in replication factors such as single
stranded DNA-binding proteins or helicase proteins [48].
However, the strongest mutator phenotypes (up to 400-fold
increase in mutation rate) often result from 30 exonuclease
inactivation in T4 [47]. Similar results were obtained with
herpes simplex virus type 1 (HSV-1), for which mutations
in the conserved regions of the polymerase domain were
found to modify replication fidelity. A HSV-1 polymerase
mutant containing Y577H/D581A substitutions was
exonuclease-deficient and exhibited a mutator phenotype.
However, this variant rapidly evolved a compensatory
substitution (L774F) that restored DNA replication fidelity
in this genetic background [49, 50]. Since RNA virus
polymerases typically lack this activity, no such mutators
can be produced, except for coronaviruses [51]. Further-
more, the genetic diversity of RNA viruses is probably
closer to an upper tolerability limit beyond which the
population genetic load increases to levels incompatible
with virus survival [3, 52]. Therefore, both biochemical
and population-genetic factors limit the appearance of
strong mutators in RNA viruses.
Host-encoded mutation rate modifiers in RNA
and reverse-transcribing viruses
Whereas post-replicative repair probably plays a role in
determining DNA virus mutation rates (as discussed
above), RNA virus mutation rates are strongly influenced
by other host-encoded factors. Apolipoprotein B mRNA-
editing catalytic polypeptide-like enzymes (APOBEC) are
a family of cellular cytidine deaminases that function as an
innate cellular defense against retroviruses [53]. This
family has expanded and diverged throughout vertebrate
evolution and includes five APOBECs [54]. APOBEC3G
was first shown to massively convert cytidines to uracils in
the complementary HIV-1 DNA during or following
reverse transcription [55–57]. APOBEC activity is antag-
onized by the viral protein Vif, which binds to and
promotes the proteasomal degradation of APOBEC [58].
There are seven APOBEC3 paralogs in the human genome
(A–D and F–H) which have been shown to also edit
retroelements and other viruses, including hepatitis B virus
[59], papillomaviruses [60], and herpesviruses [61]. Edit-
ing is strongly dependent on sequence-context. The major
determinant of editing for human APOBECs is the -1
base, thus defining typical dinucleotide targets (the edited
base and the -1 base). APOBEC3G prefers CC dinu-
cleotides whereas the other APOBEC forms prefer TC
dinucleotides. DNA editing hotspots have been identified
and depend both on sequence context and DNA secondary
structure [62]. In HIV-1, editing of the complementary
DNA strand produces GG-to-AG or GA-to-AA mutations
in the genomic RNA. In recent work, we have estimated
the relative contributions of host APOBECs and the viral
RT to the total HIV-1 mutation rate in vivo [63]. We found
that the vast majority of mutations (98 %) are produced by
APOBECs and that this elevates the HIV-1 mutation rate by
[40-fold above the RT error rate, making HIV-1 the
fastest mutating virus described so far. In many cases,
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hyper-mutation leads to loss of infectivity and hence
effectively exerts its antiviral action. However, APOBECs
can also produce moderately mutated, viable viruses, thus
raising the question whether these deaminases may con-
tribute to viral diversity and evolution, immune escape, and
drug resistance [64–66].
Double-strand RNA-dependent adenosine deaminases
(ADARs) are another type of host enzymes that edit viral
genomes by deaminating adenosines in long double-stran-
ded RNA and converting them to inosines. The latter base-
pair with guanosines, resulting in A-to-G base substitutions
[67]. ADARs also exhibit sequence context preferences,
although less marked than in the case of APOBECs [68].
ADAR-driven hyper-mutation was first demonstrated in
measles virus [69] and has since been suggested for a
variety of RNA viruses including human parainfluenza
virus [70], respiratory syncytial virus [71], lymphocytic
choriomeningitis virus [72], Rift Valley fever virus [73],
and noroviruses [74].
Lastly, other cellular proteins such as uracil DNA gly-
cosylases (UNG) can modulate viral mutation rates. Uracil
can be found in DNA abnormally due to spontaneous or
enzymatically induced cytidine deamination, leading to
G-to-A mutations. To avoid the deleterious effects of uracil
in DNA, UNG recognizes and excises uracil residues pre-
sent in DNA. The HIV-1 protein Vpr interacts with UNG
and mediates its incorporation into HIV-1 virions. Failure
to incorporate UNG produces a fourfold increase of the
HIV-1 mutation rate in actively dividing cells, and of
18-fold in macrophages [75, 76]. Variations in the con-
centration and balance of dNTPs among cell types may
also influence viral mutation rates [77]. Although analysis
of HIV-1 mutations in various cell lines revealed no
obvious mutation rate differences, it nevertheless showed
differences in the type of mutations produced [78].
Mutation accumulation is determined
by replication mode
In contrast to cells, viruses can adopt a variety of replica-
tion modes. Replication is said to follow a ‘‘stamping
machine’’ model if a single template is used to produce all
progeny strands within a given cell (Fig. 3a). Under this
theoretical model, there is only one round of copying per
cell. In practice, this means that each infecting genome is
used to synthesize a single reverse-complementary inter-
mediate which in turn is used as template for synthesizing
all progeny genomes. This contrasts with semi-conserva-
tive replication, in which each strand is copied once to
produce progeny molecules that are, in turn, used as tem-
plates in the next round of copying. Since under semi-
conservative replication the number of strands doubles in
each cycle, the virus necessarily has to undergo multiple
replication cycles within each cell to produce enough
progeny. Under stamping machine replication the mutation
frequency observed after one cell infection equals the
mutation rate, but under semi-conservative replication this
frequency is also determined by the number of replication
cycles, as mutants become amplified. This means that a
given viral polymerase will produce more mutations per
cell if replication is semi-conservative than if replication is
stamping machine-like. These two models are indeed two
extremes of a continuum of possible replication modes. For
instance, a virus can produce multiple progeny molecules
per round of copying which then undergo a second repli-
cation cycle in the same cell to end up producing hundreds
or thousands of progeny molecules.
It has been suggested that the stamping machine model
has been selectively favored in RNA viruses because it
compensates for the extremely high error rate of their
polymerases [79–81]. Some RNA viruses such as bacte-
riophage /6 [82], bacteriophage Qb [83] and turnip mosaic
virus [84] tend to replicate via the stamping machine
model. However, empirically-informed modeling of the
poliovirus replication cycle indicated multiple rounds of
copying per cell [85]. Similarly, single-cell analysis of the
genetic diversity produced by vesicular stomatitis virus
revealed that some mutations are amplified within cells,
implying that multiple rounds of copying take place per
cell [86]. However, it remains unknown whether a given
virus can modify its replication mode in response to
specific selective pressures in order to promote or down-
regulate mutational output. To a large extent, the replica-
tion mode of most viruses should be dictated by the
molecular mechanisms of replication and, hence, should be
subjected to strong functional constraints. For instance,
bacteriophage /X174 replicates via the stamping machine
mode because it uses rolling circle replication [87, 88]. In
contrast, semi-conservative replication is probably the only
mechanistically feasible replication model for viruses with
large DNA genomes.
Lysis time as a regulator of mutational output
Changes in lysis time can be thought of as another mech-
anism for regulating the production of mutations in viral
populations. Lysis is a tightly regulated process and, in
theory, viral fitness is maximized for some intermediate
lysis time [89–91]. If lysis occurs before this optimum, the
infected cell will release a small amount viral progeny and
hence few cells will be infected in the next infection cycle,
retarding population growth. Yet if lysis occurs after the
optimum, a large amount of progeny will be produced per
cell but cell-to-cell transmission will be delayed. The
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optimal lysis time depends on the time required to start
producing progeny virions (lag/eclipse time), the capacity
of infected cells to produce virions (yield) and virus/host
population densities (multiplicity of infection). However,
the optimum can also vary according to mutation rate.
Bacteriophage /X174 experimental populations treated
with the nucleoside analog 5-fluorouracil showed increased
mutation frequency and reduced growth [92]. As opposed
to other viruses, polymerase fidelity variants cannot evolve
in response to this type of treatment because bacteriophage
/X174, as well as other small DNA viruses, does not code
for a polymerase. Interestingly, 5-fluorouracil selected for
an amino acid replacement in the N-terminal region of the
phage lysis protein (V2A). This change conferred partial
resistance to the drug, but also delayed lysis [93]. In turn,
delayed lysis was concomitant with an increase in the viral
yield per cell, since progeny virions had more time to
accumulate intracellularly. Therefore, at the population
level, growth of the V2A variant occurred through longer
infection cycles with increased per-cell productivity.
However, because the virus replicates following a stamping
machine model, each infection cycle should involve only
one round of copying regardless of lysis time. As a result,
population growth required fewer total rounds of copying
in the delayed lysis variants than in the wild-type, meaning
that mutations had fewer opportunities to accumulate
(Fig. 3b). Therefore, delayed lysis increased the ability of
the phage to tolerate mutagenesis.
Template-dependent effects on mutation rate
The fidelity of a given polymerase varies according to
certain template properties. It is well known that
misalignments at homopolymeric runs can cause frameshift
mutations and base substitutions [94]. Sequence context
may influence the fidelity of HIV-1 RT by modulating
enzyme binding and dissociation [95]. Also, RNA sec-
ondary structures have been shown to promote template
switching, a process that does not lead to new mutations
but produces recombinant viruses [96–98]. In recent work,
we found that RNA structure can also modulate the fidelity
of HIV-1 RT [99]. Shuttle vectors are systems in which
most or all sequences except essential cis-acting elements
(such as the Rev-responsive element or long terminal
repeats) have been removed from the viral genome. Shuttle
vectors allow propagating HIV-1 in the absence of selec-
tion because all required functions are provided in trans by
helper plasmids that are freshly provided in each infection
cycle [100] (Fig. 4a). The shuttle vector simply carries
forward sequences of interest, which can be reporter genes
for selecting and visualizing transduced cells, or transgenes
for engineering purposes. However, the vector also accepts
HIV-1 sequences. These will have no role in the infection
cycle, as they are not expressed. Because selection is
absent, such HIV-1 sequences cloned in a shuttle vector
can be used for interrogating the viral mutation rate in
cognate templates, which is helpful for testing the effects
of sequence context or RNA structure on mutation rate.
Using this system, we recently characterized the distri-
bution of mutations along the HIV-1 envelope, integrase,
vif, and vpr genes [99]. We found that a 1 kb region
encompassing the V1–V5 loops of the gp120 envelope
protein accumulated approximately three times fewer
mutations than other regions of the HIV-1 genome. This
Fig. 3 Viral replication modes and mutation accumulation. a Stamp-
ing machine versus semi-conservative replication. As opposed to
cells, which use only semi-conservative replication, viruses can adopt
a variety of replication modes. In the stamping machine model, a
single template strand is used to synthesize all progeny genomes
within a given cell. However, this is not possible in practice because
replication requires synthesis of complementary strands or ‘‘anti-
genomes’’ (blue). Under this model, the mutation frequency after one
cell infection cycle will equal the mutation rate except if mutations
occur during the first round of copying (from genome to anti-
genome), in which case they will be present in all of the viral
progeny. Under semi-conservative replication, multiple rounds of
copying are required to produce enough progeny, thus allowing for
the intra-cellular accumulation of mutations. b Relationship between
lysis time and mutation accumulation. Longer cell infection cycles
(late burst) can allow for the production of more progeny viruses.
Under semi-conservative replication, this will require more rounds of
copying but, if replication follows the stamping machine model, the
number of rounds of copying will not change (more progeny genomes
will be produced from the same template). Hence under this model, a
late-burst virus variant will undergo fewer total rounds of copying at
the population scale than early-burst variants and will tend to
accumulate fewer mutations
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coldspot mapped to the outermost domains of gp120,
which are preferred targets of circulating antibodies and
show extensive glycosylation. Examination of this region
revealed two differential properties. First, it contained
fewer-than-expected GG and GA dinucleotides, which are
the preferred sequence contexts of APOBEC3, as previ-
ously discussed [101, 102]. As a result, APOBEC-driven
G-to-A mutations were less frequent in V1–V5 than in
other genome regions. Second, using the RNA structure
morel previously determined by selective 20-hydroxyl
acylation analyzed by primer extension (SHAPE), we
found that this 1 kb region exhibited significantly fewer
RNA base-pairs than other regions of the envelope gene
[103]. To more directly test the effect of RNA structure on
HIV-1 RT fidelity, we used in vitro polymerization assays
with two different templates: a random sequence and RNA
from potato spindle tuber viroid, which shows a marked,
stem-like secondary structure [104]. We found an increased
RT error rate in the viroid RNA compared to the random
sequence, suggesting that RT fidelity decreases in highly
structured RNA.
Using a conceptually similar approach, we recently
characterized the accumulation of mutations along the
HCV genome under weak or no selection using a bicis-
tronic replicon by cloning HCV sequences at a site
commonly used for inserting reporter genes (Fig. 4b). This
revealed extreme mutation rate variations across individual
nucleotide sites of the viral genome, with differences of
orders of magnitude even between adjacent sites [105]. In
that system, we found little or no effect of RNA structure
on mutation rate, but a more significant effect of base
identity, such that A and U bases were more prone to
mutation than G and C.
Targeted hyper-mutation in viruses
The finding that HIV-1 has a reduced mutation rate in the
genome region encoding the outermost domains of the
gp120 envelope protein reveals an uncoupling between
mutation rate and genetic diversity, as these domains are
the most variable regions of the HIV-1 genome, mainly as
a consequence of immune pressure [106]. This indicates
that HIV-1 has not evolved the ability to target mutation to
regions wherein they are more likely to be needed for
adaptation. A possible evolutionary explanation for the
gp120 V1–V5 coldspot is that some APOBEC-driven
mutations favored by immune pressure during HIV-1
evolutionary history resulted in loss of APOBEC targets,
leading to a subsequent reduction in mutation rate. Simi-
larly, strong selection at the protein level may have favored
amino acid replacements within this region even at the cost
of disrupting pre-existing RNA secondary structures and,
as a consequence, these RNA structural changes would
have modified replication fidelity [99]. In HCV, we found
no significant differences in mutation rate across genes
[105], as opposed to genetic variation, which concentrates
in specific genomes regions including external domains of
Fig. 4 Cell culture systems for the accumulation of mutations in the
absence of selection. a HIV-1 shuttle vector. The vector contains only
cis-acting HIV-1 sequences such as the Rev-responsive element
(RRE), the encapsidation signal (W), and the long terminal repeats
(LTR). A resistance gene (RES, red) is inserted to allow for the
selection of cells containing the vector. Any (short) sequence of
interest (SEQ, blue), including HIV sequences, can be cloned in the
shuttle vector and propagated in the absence of selection. The shuttle
vector DNA is co-transfected with helper plasmids encoding the Gag
(capsid) and Pol (RT, integrase) proteins as well as a viral
glycoprotein suited for transducing a given cell line (here vesicular
stomatitis G protein, VSV-G, which has a broad tropism). Pseudo-
typed viruses are produced, used for transduction, and cells carrying
the retroviral shuttle vector are selected with the appropriate
antibiotic. The infection cycle can be restarted at any time by
transfecting the two helper plasmids. The SEQ DNA is then extracted,
PCR-amplified, and sequenced to score mutations. b HCV replicon.
Two cistrons are separated by an internal ribosome entry site (IRES).
The right cistron encodes HCV non-structural (NS) proteins required
for replication, but lacks the envelope proteins and hence does not
support viral budding. The left replicon carries a resistance gene to
select cells carrying the replicon. Reporters such as luciferase can be
also cloned in this cistron. Since these play no function, they can be
replaced with any short sequence of interest (SEQ), including HCV
sequences. Replicon RNA is obtained by in vitro transcription and
transfected into Huh7 hepatoma cells. Cells are selected using the
appropriate antibiotic and passaged before confluence to allow
vigorous replication of the viral RNA. The SEQ RNA is reverse-
transcribed, PCR-amplified, and sequenced to score mutations
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the E2 envelope protein [107]. This again supports the view
that RNA viruses cannot target mutations to specific gen-
omes regions to improve their adaptability.
This contrasts with bacteria and DNA viruses, in which
mechanisms of error-prone replication have evolved at
specific loci involved in host-pathogen interactions
[108–110]. A well-characterized system of mutation tar-
geting, called diversity-generating retro-elements (DGRs),
is found in large DNA bacteriophages [110]. DGRs are
typically located in genes involved in host attachment, a
step of the infection cycle that is subject to rapid changes
depending on host species availability. DGRs were first
identified in the Bordetella BPP-1 bacteriophage [111], and
always contain two sequence repeats called variable repeat
(VR) and template repeat (TR). The BPP-1 VR is located
in the 30 end of the mtd gene (major tropism determinant),
which encodes a tail fiber protein. The TR is located
downstream of the VR and has a highly conserved
sequence, in contrast to the VR. An RT is also encoded by
the DGR and synthesizes a cDNA from the TR transcript, a
process during which extensive mutagenesis of adenines
takes place by a key unknown mechanism. The cDNA is
then transferred to the VR, producing a large number of
variants of the mtd gene capable of interacting with new
host ligands [112]. Some hypervariable genes in DNA
viruses from the human lower gastrointestinal tract show
homology with the BPP-1 DGR, and most of these loci are
linked to RT genes, suggesting the presence of DGRs
[113]. DGRs have also been described in plasmids, bac-
terial and archaeal chromosomes, and archaeal viruses
[114–116]. It therefore appears that at least some
prokaryotic DNA viruses have evolved the ability to target
mutations to specific regions, as opposed to RNA viruses.
Interplays between mutation and recombination
Diversity-generating retro-elements have not been descri-
bed in eukaryotic viruses, but these viruses can use other
mechanisms of mutational targeting that involve recombi-
nation. The inverted terminal repeats of vaccinia virus
contain 10–100 base repeated sequence motifs known to
experience frequent unequal crossover events and rapid
changes in copy number [117, 118]. Recombination has
been shown to promote the rapid production of genetic
diversity in other genome regions of the vaccinia virus
involved in immune escape and the colonization of novel
hosts. Protein kinase R (PKR) is a central effector of innate
antiviral immunity that induces translational shutoff,
modifies protein phosphorylation status, alters mRNA sta-
bility, and induces apoptosis [119]. Poxvirus proteins K3L
and E3L block PKR and have evolved as antagonists of
innate immune responses in a host-specific manner
[120, 121]. Experimental deletion of E3L renders vaccinia
virus more susceptible to host antiviral responses, imposing
a strong selection pressure in the other PKR suppressor
K3L to increase its function [108]. Serial transfers of E3L-
deleted vaccinia virus led to an elevated K3L copy number,
a recombination-driven process that allowed the virus to
overexpress this gene. This gain-of-function mutation had a
direct fitness benefit, but also increased the number of
available targets for the appearance of subsequent selec-
tively advantageous point mutations in K3L. Remarkably,
upon selection of these mutants K3L copy numbers were
again reduced. Hence, recombination led to an evolution-
ary process characterized by expansion and contraction of a
specific genome region. These so-called genomic accor-
dions have been posited to mediate adaptive duplications in
other poxviruses such as myxoma virus [122].
Interesting interplays between recombination andmutation
rates have also been recently found inRNAviruses. These two
processes are primarily controlled by the viral polymerase
since, in RNA viruses, recombination takes place when the
viral polymerase switches between different template gen-
omes present in the same cell [123]. The estimated
recombination rates of different riboviruses and retroviruses
correlate positively with estimated mutation rates [124]. High
mutation rates confer viruses the ability to rapidly produce
advantageousmutations, but also inflate thegenetic loadof the
population. In turn, frequent recombination allows beneficial
mutations to unlink from deleterious genetic backgrounds, as
well different beneficial mutations to be combined into the
same genome. As such, recombination is expected to enhance
adaptation when a large number of alleles coexist in the same
population, a scenario that typically takes place at high
mutation rates [125]. Experimental evidence supporting the
joint effects of recombination and mutation rates in viral
adaptability has been recently obtained using poliovirus
polymerase mutants that individually alter replication fidelity
or recombination rate [126]. In another recent work, a low-
fidelity variant of Sindbis virus was found to exhibit increased
recombination [127]. This variant showed low fitness and a
greater tendency to accumulate defective interfering particles
(i.e. mutant viruses with large deletions that depend on and
interfere with the wild-type infection cycle). Therefore, it
appears that high mutation and recombination rates enhance
viral adaptability, but only up to a certain point, beyondwhich
both processes contribute to the accumulation of deleterious
alleles in the population.
Conclusions
Viral mutation rates are determined by multiple processes,
including polymerase intrinsic fidelity, replication mode, 30
exonuclease activity, spontaneous nucleic acid damage,
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access to post-replicative repair, editing by host-encoded
deaminases, imbalances in nucleotide pools, template
sequence context, and template structure, as summarized in
Table 2. Some of these processes underlie large-scale
patterns of variation among viruses, such as differences
between RNA and DNA viruses, between viruses with
small and large genomes, and between single-strand and
double-strand viruses, but important mechanistic aspects
behind these differences still remain uncharacterized.
Furthermore, mutation rates are not static and can evolve in
response to selective pressures, as exemplified by fidelity
variants selected under mutagenic conditions in a variety of
viruses. In addition to polymerase fidelity, other mutation
rate-determinants such as access to DNA repair may have
also changed in response to selective pressures during viral
evolution.
In RNA viruses, both low- and high-fidelity polymerase
variants tend to have a negative impact in viral fitness in
complex environments, suggesting that RNA virus muta-
tion rates have been evolutionarily optimized. Given that
DNA virus mutation rates are substantially lower than
those of RNA viruses this also suggests that DNA viruses
show suboptimal mutation rates for adaptation to rapidly
changing environments, despite RNA and DNA viruses
sharing similar lifestyles. It appears that large DNA viruses
have adopted a different and more elaborate strategy con-
sisting of targeting mutations to specific genome regions
subject to rapidly varying selective pressures, such as genes
encoding attachment proteins or inhibitors of innate
immunity responses. Mutation targeting mechanisms such
as DGRs and recombination-driven gene copy amplifica-
tion are probably not accessible to small DNA viruses with
compact genomes. Furthermore, mutation rate evolution in
small DNA viruses is further constrained by the fact they
do not encode autonomous replication systems. Therefore,
small DNA viruses should rely on repair avoidance and on
use of host-encoded error-prone DNA polymerases to
elevate their mutation rates and achieve faster adaptation.
Elucidating the mutational mechanisms of small DNA
viruses is a current challenge in virus molecular biology
and evolution. Other exciting unresolved questions include
unveiling the interplays between mutation and recombi-
nation, the roles played by viral accessory proteins in
determining mutation rates, the effects of host-encoding
enzymes on viral diversity and evolution, whether mutation
accumulation can be evolutionary adjusted by modifying
viral replication modes, and how template sequences reg-
ulate viral mutation rates.
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